关注
Xin Xu
Xin Xu
在 ksu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
The C1q receptors: focus on gC1qR/p33 (C1qBP, p32, HABP-1) 1
B Ghebrehiwet, BV Geisbrecht, X Xu, AG Savitt, EIB Peerschke
Seminars in Immunology 45, 101338, 2019
712019
Genetic diversity of Plasmodium falciparum populations in southeast and western Myanmar
TN Soe, Y Wu, MW Tun, X Xu, Y Hu, Y Ruan, AYN Win, MH Nyunt, ...
Parasites & vectors 10, 1-6, 2017
462017
Seasonal dynamics and microgeographical spatial heterogeneity of malaria along the China–Myanmar border
Y Hu, G Zhou, Y Ruan, M Lee, X Xu, S Deng, Y Bai, J Zhang, J Morris, ...
Acta tropica 157, 12-19, 2016
382016
SARS-CoV-2 exacerbates COVID-19 pathology through activation of the complement and kinin systems
AG Savitt, S Manimala, T White, M Fandaros, W Yin, H Duan, X Xu, ...
Frontiers in Immunology 12, 767347, 2021
372021
Microgeographic heterogeneity of border malaria during elimination phase, Yunnan Province, China, 2011–2013
X Xu, G Zhou, Y Wang, Y Hu, Y Ruan, Q Fan, Z Yang, G Yan, L Cui
Emerging infectious diseases 22 (8), 1363, 2016
192016
Process improvement for fermentation coupling with foam separation: a convenient strategy for cell recycle
D Zhang, K Dong, D Xu, H Zheng, Z Wu, X Xu
Asia‐Pacific Journal of Chemical Engineering 10 (3), 466-475, 2015
132015
Inhibition of the complement alternative pathway by chemically modified DNA aptamers that bind with picomolar affinity to factor B
X Xu, C Zhang, DT Denton, D O’Connell, DW Drolet, BV Geisbrecht
The Journal of Immunology 206 (4), 861-873, 2021
122021
Associations among soil-transmitted helminths, G6PD deficiency and asymptomatic malaria parasitemia, and anemia in schoolchildren from a conflict zone of northeast Myanmar
W Zeng, P Malla, X Xu, L Pi, L Zhao, X He, Y He, LJ Menezes, L Cui, ...
The American Journal of Tropical Medicine and Hygiene 102 (4), 851, 2020
112020
AI is a viable alternative to high throughput screening: a 318-target study
Scientific reports 14 (1), 7526, 2024
92024
Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl) Pyridine-3-Carboximidamide and Chemical Analogs
X Xu, TJ Herdendorf, H Duan, DL Rohlik, S Roy, H Zhou, H Alkhateeb, ...
The Journal of Immunology 212 (4), 689-701, 2024
32024
gC1qR/C1qBP/HABP-1: structural analysis of the trimeric core region, interactions with a novel panel of monoclonal antibodies, and their influence on binding to FXII
Y Zhang, AJ Vontz, EM Kallenberger, X Xu, NT Ploscariu, KX Ramyar, ...
Frontiers in Immunology 13, 887742, 2022
32022
Group B Streptococcus Surface Protein β: Structural Characterization of a Complement Factor H–Binding Motif and Its Contribution to Immune Evasion
X Xu, AL Lewis Marffy, A Keightley, AJ McCarthy, BV Geisbrecht
The Journal of Immunology 208 (5), 1232-1247, 2022
22022
Structural/functional analysis of complement proteins and inhibitions
X Xu
Kansas State University, 2022
2022
Structural and Interaction Insight in Streptococcal beta C Proteins
X Xu, N van Sorge, S van der Lans, E van Woudenbergh, J van Strijp, ...
The FASEB Journal 34 (S1), 1-1, 2020
2020
Expression, purification, and characterization of a human complement component C3 analog that lacks the C-terminal C345c domain
KX Ramyar, X Xu, NM White, A Keightley, BV Geisbrecht
Journal of immunological methods 473, 112633, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–15